米国企業
ABEONA THERAPEUTICS INC.

ABEONA THERAPEUTICS INC.ABEO

時価総額

$1.4億

PER

	2011年 12月31日	2012年 12月31日	2013年 12月31日	2014年 12月31日	2015年 12月31日	2016年 12月31日	2017年 12月31日	2018年 12月31日	2019年 12月31日	2020年 12月31日	2021年 12月31日	2022年 12月31日
Cash and cash equivalents	2	396,000	424,000	12	40	69	138	19	129	13	33	14
Short-term investments	-	-	-	-	-	-	-	66	-	82	12	38
Restricted cash	-	-	-	-	-	-	-	-	-	-	-	0
Accounts receivable	-	-	-	-	-	-	-	-	-	-	3	-
Other receivables	-	-	-	-	-	-	-	-	-	-	-	0
Prepaid expenses and other current assets	39,000	251,000	77,000	-	315,000	155,000	3	4	3	3	7	0
Total current assets	3	2	575,000	12	41	69	141	89	132	98	55	53
Property and equipment, net	51,000	7,000	6,000	4,000	350,000	721,000	1	9	13	11	12	6
Right-of-use lease assets	-	-	-	-	-	-	-	-	8	7	9	5
Licensed technology, net	362,000	-	-	5	7	8	4	43	36	2	1	-
Other assets	59,000	42,000	32,000	32,000	62,000	66,000	-	-	-	-	-	0
Total assets	4	2	613,000	17	80	111	179	174	223	151	80	64
Accounts payable	2	2	863,000	2	875,000	4	2	6	4	5	4	2
Accrued expenses	857,000	857,000	857,000	-	-	-	-	4	6	3	6	4
Current portion of lease liability	-	-	-	-	-	-	-	-	2	2	2	2
Current portion of payable to licensor	-	-	-	-	-	-	-	-	27	32	5	-
Other current liabilities	-	-	-	-	-	-	-	-	-	-	-	0
Total current liabilities	12	7	9	3	1	8	6	20	39	42	17	8
Payable to licensor	-	-	-	-	-	-	-	-	-	-	4	4
Long-term lease liabilities	-	-	-	-	-	-	-	-	6	5	8	6
Warrant liabilities	-	-	-	-	-	-	-	-	-	-	-	20
Other long-term liabilities	-	-	-	-	-	-	-	-	-	-	200,000	-
Total liabilities	21	19	15	12	12	12	9	40	45	49	28	37
Preferred stock - $0.01 par value; authorized 2,000,000 shares; No shares issued and outstanding as of December 31, 2022 and December 31, 2021, respectively	-	-	-	-	-	-	-	-	-	-	-	-
Common stock - $0.01 par value; authorized 200,000,000 shares; 17,719,720 and 5,888,217 shares issued and outstanding as of December 31, 2022 and December 31, 2021, respectively	239,000	247,000	257,000	200,000	328,000	403,000	469,000	479,000	836,000	961,000	1	0
Additional paid-in capital	238	251	251	301	378	-	-	-	-	-	-	722
Accumulated deficit	-255,441,000	-267,972,000	-266,421,000	-296,074,000	-310,600,000	-332,473,000	-359,792,000	-410,188,000	-486,470,000	-570,704,000	-655,640,000	-695
Accumulated other comprehensive loss	-	-	-	-	-	-	-	-	-	-10,000	-27,000	-0
Total stockholders’ equity	-17,606,000	-17,076,000	-14,779,000	5	68	99	170	134	178	103	51	27
Total liabilities and stockholders’ equity	4	2	613,000	17	80	111	179	174	223	151	80	64